[HTML][HTML] Inflammation in COVID-19: from pathogenesis to treatment
RSY Wong - International journal of clinical and experimental …, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) was declared a pandemic in March
2020 by the World Health Organization (WHO). To date, there were> 163 million confirmed …
2020 by the World Health Organization (WHO). To date, there were> 163 million confirmed …
A review on immunological responses to SARS-CoV-2 and various COVID-19 vaccine regimens
S Upreti, M Samant - Pharmaceutical Research, 2022 - Springer
The transmission of SARS-CoV-2 has caused serious health crises globally. So far, 7
vaccines that are already being assessed in Phase IV clinical trials are, Comirnaty/Pfizer; …
vaccines that are already being assessed in Phase IV clinical trials are, Comirnaty/Pfizer; …
Pathophysiology and clinical manifestations of COVID-19-related acute kidney injury—the current state of knowledge and future perspectives
I Smarz-Widelska, E Grywalska, I Morawska… - International Journal of …, 2021 - mdpi.com
The continually evolving severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic has resulted in a vast number of either acute or chronic medical impairments of a …
pandemic has resulted in a vast number of either acute or chronic medical impairments of a …
Characterisation of the blood RNA host response underpinning severity in COVID-19 patients
H Jackson, I Rivero Calle, C Broderick… - Scientific reports, 2022 - nature.com
Infection with SARS-CoV-2 has highly variable clinical manifestations, ranging from
asymptomatic infection through to life-threatening disease. Host whole blood transcriptomics …
asymptomatic infection through to life-threatening disease. Host whole blood transcriptomics …
Cannabis as antivirals
Cannabis is a plant notorious for its psychoactive effect, but when used correctly, it provides
a plethora of medicinal benefits. With more than 400 active compounds that have …
a plethora of medicinal benefits. With more than 400 active compounds that have …
[HTML][HTML] Study of baicalin toward COVID-19 treatment: in silico target analysis and in vitro inhibitory effects on SARS-CoV-2 proteases
Negative impacts of COVID-19 on human health and economic and social activities urge
scientists to develop effective treatments. Baicalin is a natural flavonoid, extracted from a …
scientists to develop effective treatments. Baicalin is a natural flavonoid, extracted from a …
Impact of vitamin D therapy on the progress COVID-19: six weeks follow-up study of vitamin D deficient elderly diabetes patients
AR Soliman, TS Abdelaziz… - … of Singapore Healthcare, 2022 - journals.sagepub.com
Background Coronavirus disease-19 (COVID-19) is an ongoing pandemic causing
considerable fatalities worldwide. Vitamin D modulates the immune response through …
considerable fatalities worldwide. Vitamin D modulates the immune response through …
Targeting the complement cascade in the pathophysiology of COVID-19 disease
N Ng, CA Powell - Journal of Clinical Medicine, 2021 - mdpi.com
Severe coronavirus disease 2019 causes multi-organ dysfunction with significant morbidity
and mortality. Mounting evidence implicates maladaptive over-activation of innate immune …
and mortality. Mounting evidence implicates maladaptive over-activation of innate immune …
HMGB1 mediates microbiome-immune axis dysregulation underlying reduced neutralization capacity in obesity-related post-acute sequelae of SARS-CoV-2
NC Rubas, R Peres, BP Kunihiro, NP Allan… - Scientific Reports, 2024 - nature.com
While obesity is a risk factor for post-acute sequelae of SARS-CoV-2 infection (PASC," long-
COVID"), the mechanism (s) underlying this phenomenon remains poorly understood. To …
COVID"), the mechanism (s) underlying this phenomenon remains poorly understood. To …
Critically ill COVID-19 patients show reduced point of care-measured butyrylcholinesterase activity—a prospective, monocentric observational study
F Espeter, D Künne, L Garczarek, H Kuhlmann… - Diagnostics, 2022 - mdpi.com
A biomarker for risk stratification and disease severity assessment in SARS-CoV-2 infections
has not yet been established. Point of care testing (POCT) of butyrylcholinesterase (BChE) …
has not yet been established. Point of care testing (POCT) of butyrylcholinesterase (BChE) …